Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Cognition, Age, and RaPamycin Effectiveness - DownregulatIon of thE mTor Pathway (CARPE DIEM)

Authors not listed

The University of Texas Health Science Center at San Antonio · 2020

Abstract

Evaluation of central nervous system penetration of orally administered Rapamune (RAPA) in older adults with Mild Cognitive Impairment (MCI) or early Alzheimer's disease (AD) and investigate associated safety, tolerability, target engagement, cognition, and functional status as initial proof-of-concept study

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-13 MST

Cite this

APA
Anonymous. (2020). Cognition, Age, and RaPamycin Effectiveness - DownregulatIon of thE mTor Pathway (CARPE DIEM). <em>The University of Texas Health Science Center at San Antonio</em>. https://clinicaltrials.gov/study/NCT04200911
Vancouver
Anonymous. Cognition, Age, and RaPamycin Effectiveness - DownregulatIon of thE mTor Pathway (CARPE DIEM). The University of Texas Health Science Center at San Antonio. 2020.
BibTeX
@misc{anon2020Cognit, title = {Cognition, Age, and RaPamycin Effectiveness - DownregulatIon of thE mTor Pathway (CARPE DIEM)}, author = {Anonymous}, journal = {The University of Texas Health Science Center at San Antonio}, year = {2020}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings